WW Improving Nutrition Study: A Randomized Controlled Trial

Launched by GEORGIA SOUTHERN UNIVERSITY · Dec 5, 2022

Keywords

ClinConnect Summary

The WW Unlimited Workshops and Digital Program is an evidence-based behavioral weight management program that guides members toward personal weight and wellness goals through a personalized curriculum, complemented with behavioral weekly goals to drive healthy habits. The program includes foods that can be eaten in moderation without the need to tracking, as well as a points system that rates foods. In addition, members have access to food, activity, water, sleep, and weight trackers, meal planning tools, recipes, guided meditations and workouts, peer support, and access to online workshops...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Self-reported desire to lose weight
• • English proficiency
• • Ages: 18 - 70 years old
• • BMI between 27-45 kg/m2
• • Owns a smartphone with a camera
• • Wi-Fi connectivity at home
• • Willing to follow recommendations required by study protocol
• • Willing to actively participate in a behavioral weight loss program for 6 months and to attend virtual workshop meetings
• • Willing to include demographic information (e.g., ethnicity, income, and education)
• • US residence (48 contiguous States)
• • Must be able to receive in the mail a weight scale.
• Exclusion Criteria:
• • Pregnant, lactating, or plans to become pregnant during study period
• • Self-reported bipolar disorder, substance abuse, psychosis, bulimia.
• • Meets criteria for severe depression on the Patient Health Questionnaire-8 (PHQ-8) (score of \>20)
• • All other mental health, including other eating disorders will be assessed using a self-report question on the initial screening survey.
• • Had bariatric surgery or plans to have any surgery during the study
• • Unable or not willing to make dietary changes or increase physical activity
• • Unable to walk ¼ mile unaided without stopping
• • Daily nicotine user: smoke, vape, tobacco, other
• • Participants that are currently trying to lose weight via a structured weight-loss program (e.g., at a medical center, university, commercial programs)
• • Participants who were a member of WW within the past 12 months
• • Participants who are involved in any other research studies at this time
• • Weight loss of ≥ 5 kg (11 lb) in the previous 6 months
• • Reported health problems that make weight loss or unsupervised exercise unsafe or unreasonable (e.g., chronic pain, orthopedic limitations, heart problems)
• • Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months
• • Taking any prescription medication with known effects on appetite or weight (e.g., oral steroids, weight loss medications such as Qysmia, Contrave, Phentermine (Adipex-P, Lomaira) and others except for subjects on a stable dose of Selective serotonin reuptake inhibitors (SSRIs) for 6 months or longer
• • Chronic/inflammatory gastrointestinal disorders (irritable bowel syndrome is acceptable)
• • History of heart problems (e.g., angina, bypass surgery, myocardial infarction, etc.) within previous 6 months
• • Diagnosis of type 1 or type 2 diabetes
• • Major surgery within the previous 6 months
• • Presence of implanted cardiac defibrillator or pacemaker
• • History of cancer within past 5 years or current treatment for cancer
• • Hospitalization for psychiatric disorders during the past 12 months

Trial Officials